Higher order organization of human placental aromatase

被引:17
作者
Ghosh, Debashis [1 ]
Jiang, Wenhua [1 ]
Lo, Jessica [1 ]
Egbuta, Chinaza [1 ]
机构
[1] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA
基金
美国国家卫生研究院;
关键词
Aromatase; Estrogen; Androgen; Oligomer; Crystal structure; ELECTRON-TRANSFER; BREAST-CANCER; INHIBITORS;
D O I
10.1016/j.steroids.2011.02.030
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aromatase (CYP19A1) is an integral membrane enzyme that catalyzes the removal of the 19-methyl group and aromatization of the A-ring of androgens. All human estrogens are synthesized from their androgenic precursors by this unique cytochrome P450. The crystal structure of active aromatase purified from human placenta has recently been determined in complex with its natural substrate androstenedione in the high-spin ferric state of heme. Hydrogen bond forming interactions and tight packing hydrophobic side chains closely complement puckering of the steroid backbone, thereby providing the molecular basis for the androgenic specificity of aromatase. In the crystal, aromatase molecules are linked by a head-to-tail intermolecular interaction via a surface loop between helix D and helix E of one aromatase molecule that penetrates the heme-proximal cavity of the neighboring, crystallographically related molecule, thus forming in tandem a polymeric aromatase chain. This intermolecular interaction is similar to the aromatase-cytochrome P450 reductase coupling and is driven by electrostatics between the negative potential surface of the D-E loop region and the positively charged heme-proximal cavity. This loop-to-proximal site link in aromatase is rather unique-there are only a few of examples of somewhat similar intermolecular interactions in the entire P450 structure database. Furthermore, the amino acids involved in the intermolecular contact appear to be specific for aromatase. Higher order organization of aromatase monomers may have implications in lipid integration and catalysis. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:753 / 758
页数:6
相关论文
共 23 条
[1]   FUNCTIONAL DOMAINS OF HUMAN AROMATASE CYTOCHROME-P450 CHARACTERIZED BY LINEAR ALIGNMENT AND SITE-DIRECTED MUTAGENESIS [J].
AMARNEH, B ;
CORBIN, CJ ;
PETERSON, JA ;
SIMPSON, ER ;
GRAHAMLORENCE, S .
MOLECULAR ENDOCRINOLOGY, 1993, 7 (12) :1617-1624
[2]  
[Anonymous], 2009, VERS 2008 REL 10
[3]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[4]   Update on the use of aromatase inhibitors in breast cancer [J].
Brueggemeier, Robert W. .
EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (14) :1919-1930
[5]   Rapid Estradiol/ERα Signaling Enhances Aromatase Enzymatic Activity in Breast Cancer Cells [J].
Catalano, Stefania ;
Barone, Ines ;
Giordano, Cinzia ;
Rizza, Pietro ;
Qi, Hongyan ;
Gu, Guowei ;
Malivindi, Rocco ;
Bonofiglio, Daniela ;
Ando, Sebastiano .
MOLECULAR ENDOCRINOLOGY, 2009, 23 (10) :1634-1645
[6]   Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: A systematic review [J].
Eisen, Andrea ;
Trudeau, Maureen ;
Shelley, Wendy ;
Messersmith, Hans ;
Pritchard, Kathleen I. .
CANCER TREATMENT REVIEWS, 2008, 34 (02) :157-174
[7]   Coot:: model-building tools for molecular graphics [J].
Emsley, P ;
Cowtan, K .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2004, 60 :2126-2132
[8]   Structural basis for androgen specificity and oestrogen synthesis in human aromatase [J].
Ghosh, Debashis ;
Griswold, Jennifer ;
Erman, Mary ;
Pangborn, Walter .
NATURE, 2009, 457 (7226) :219-U119
[9]   Epitope Characterization of an Aromatase Monoclonal Antibody Suitable for the Assessment of Intratumoral Aromatase Activity [J].
Hong, Yanyan ;
Li, Hongzhi ;
Ye, Jingjing ;
Miki, Yasuhiro ;
Yuan, Yate-Ching ;
Sasano, Hironobu ;
Evans, Dean B. ;
Chen, Shiuan .
PLOS ONE, 2009, 4 (11)
[10]   Molecular Characterization of Aromatase [J].
Hong, Yanyan ;
Li, Hongzhi ;
Yuan, Yate-Ching ;
Chen, Shiuan .
STEROID ENZYMES AND CANCER, 2009, 1155 :112-120